345 related articles for article (PubMed ID: 16302701)
1. Surface markers of lymphocytes and immunoglobulin alterations in chronic lymphocytic leukemia (CLL).
Aydar S; Oğüt A; Undük H; Gündüz M
New Istanbul Contrib Clin Sci; 1978 Mar; 12(2):152-60. PubMed ID: 16302701
[No Abstract] [Full Text] [Related]
2. [Cytoplasmic immunoglobulins in chronic B-lymphoid leukemia].
Filippi JF; Nicolino-Brunet C; Tubiana N; Carcassonne Y; Sampol J
Pathol Biol (Paris); 1991 Jan; 39(1):47-9. PubMed ID: 2011410
[TBL] [Abstract][Full Text] [Related]
3. Study of cell-surface markers in chronic lymphocytic leukaemia (CLL).
Rak K; Pecze K; Kiss A; Telek B
Folia Haematol Int Mag Klin Morphol Blutforsch; 1984; 111(3):294-300. PubMed ID: 6205953
[TBL] [Abstract][Full Text] [Related]
4. Cytoplasmic immunoglobulins in B cell chronic lymphocytic leukemia (B-CLL).
Coser P; Pianezze G
Bone Marrow Transplant; 1989 Jan; 4 Suppl 1():151-2. PubMed ID: 2653493
[No Abstract] [Full Text] [Related]
5. [Immunologic phenotype of lymphocytes in chronic B-cell lymphocytic leukemia. I. B- and T-lymphocytes in chronic lymphocytic leukemia].
Rupniewska ZM; Wach M; Kowal M; Roliński J; Antosz H
Acta Haematol Pol; 1992; 23(1):21-7. PubMed ID: 1615748
[TBL] [Abstract][Full Text] [Related]
6. [Expression of proliferation marker Ki 67 in chronic lymphocytic leukemia].
Diop S; Letestu R; Orsolani D; Leboeuf Y; Le Tutour P; Thiam D; Diakhate L; Valensi F
Dakar Med; 2005; 50(2):65-8. PubMed ID: 16295759
[TBL] [Abstract][Full Text] [Related]
7. Relevance of surface markers in chronic lymphocytic leukemia to acute lymphocytic leukemia.
Aisenberg AC; Wilkes BM
Cancer Res; 1981 Nov; 41(11 Pt 2):4810-3. PubMed ID: 6975164
[TBL] [Abstract][Full Text] [Related]
8. Altered constitutive and activation-induced expression of CD95 by B- and T-cells in B-cell chronic lymphocytic leukemia.
De Fanis U; Dalla Mora L; Romano C; Sellitto A; Tirelli A; Lucivero G
Haematologica; 2002 Mar; 87(3):325-7. PubMed ID: 11869948
[TBL] [Abstract][Full Text] [Related]
9. [Chronic lymphocytic leukemia. II. Differentiation of various forms of chronic lymphocytic leukemia by cytological and immunological indicators].
Popova L; Apostolov P; Vlaĭkova S; Stamenova L
Vutr Boles; 1988; 27(3):76-80. PubMed ID: 3264645
[TBL] [Abstract][Full Text] [Related]
10. Performance of calibration standards for antigen quantitation with flow cytometry in chronic lymphocytic leukemia.
Rossmann ED; Lenkei R; Lundin J; Mellstedt H; Osterborg A
Cytometry B Clin Cytom; 2007 Nov; 72(6):450-7. PubMed ID: 17565749
[TBL] [Abstract][Full Text] [Related]
11. Different levels of CD52 antigen expression evaluated by quantitative fluorescence cytometry are detected on B-lymphocytes, CD 34+ cells and tumor cells of patients with chronic B-cell lymphoproliferative diseases.
Klabusay M; Sukova V; Coupek P; Brychtova Y; Mayer J
Cytometry B Clin Cytom; 2007 Sep; 72(5):363-70. PubMed ID: 17428002
[TBL] [Abstract][Full Text] [Related]
12. [Immunosuppressor activity of B-cells in patients with chronic lymphocytic leukemia. Their possible role in the pathogenesis of the disease].
Chernykh ER; Tikhonova MA; Ostanin AA; Shevela EIa; Blazhievich IA; Shubinskiĭ GZ
Vestn Akad Med Nauk SSSR; 1991; (12):39-43. PubMed ID: 1801472
[TBL] [Abstract][Full Text] [Related]
13. Application of a combined rosette-fluorescent test in studies on leukemia cells.
Stella-Hołowiecka B; Hołowiecki J; Szeruda-Rudzka E; Krawczyk-Kuliś M
Arch Immunol Ther Exp (Warsz); 1979; 27(1-2):165-70. PubMed ID: 375866
[TBL] [Abstract][Full Text] [Related]
14. Immunological identification of peripheral-blood lymphocytes from patients with lymphoproliferative disorders in Nigeria. II. Chronic lymphocytic leukaemia (CLL).
Ukaejiofo EO; Sagoe AS; Osunkoya BO
Afr J Med Med Sci; 1983; 12(3-4):197-202. PubMed ID: 6326554
[TBL] [Abstract][Full Text] [Related]
15. Detection of T and B cell populations in some lymphoproliferative disorders.
Herzog P; Stöckbauer P
Czech Med; 1980; 3(4):263-70. PubMed ID: 6971744
[TBL] [Abstract][Full Text] [Related]
16. Expression of inhibitory receptor ILT3 on neoplastic B cells is associated with lymphoid tissue involvement in chronic lymphocytic leukemia.
Colovai AI; Tsao L; Wang S; Lin H; Wang C; Seki T; Fisher JG; Menes M; Bhagat G; Alobeid B; Suciu-Foca N
Cytometry B Clin Cytom; 2007 Sep; 72(5):354-62. PubMed ID: 17266150
[TBL] [Abstract][Full Text] [Related]
17. T and B origin of human lymphocytic leukaemia.
Sabolović D
Cytobios; 1975; 12(46):79-88. PubMed ID: 1081030
[TBL] [Abstract][Full Text] [Related]
18. Immunophenotypic characterization of the leukemic B-cells from Iranian patients with chronic lymphocytic leukemia: association between CD38 expression and disease progression.
Hojjat Farsangi M; Jeddi-Tehrani M; Razavi SM; Sharifian RA; Shamsian Khoramabadi A; Rabbani H; Shokri F
Iran J Immunol; 2008 Mar; 5(1):25-35. PubMed ID: 18319522
[TBL] [Abstract][Full Text] [Related]
19. Phenotypic and functional changes in chronic lymphocytic leukemia.
Răileanu-Moţoiu I; Dumitrescu A
Rom J Intern Med; 1993; 31(2):99-108. PubMed ID: 8268837
[TBL] [Abstract][Full Text] [Related]
20. Signaling pathways activated by the B-cell receptor in chronic lymphocytic leukemia.
Scupoli MT; Pizzolo G
Expert Rev Hematol; 2012 Jun; 5(3):341-8. PubMed ID: 22780213
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]